XML 29 R17.htm IDEA: XBRL DOCUMENT v3.25.3
Accrued Liabilities
9 Months Ended
Sep. 30, 2025
Accrued Liabilities  
Accrued Liabilities

10. Accrued Liabilities

Accrued liabilities as of September 30, 2025 and December 31, 2024 consisted of the following:

September 30, 2025

 

December 31, 2024

Accrued royalties

$

8,117

$

13,120

Accrued interest

 

6,369

 

6,146

Accrued product taxes and fees

6,030

6,660

Accrued bonuses

5,192

8,399

Accrued payroll and related benefits

4,102

4,589

Accrued incentive compensation

3,617

4,054

Accrued inventory

2,917

6,073

Accrued sales and marketing

2,884

4,398

Accrued audit and legal

2,633

 

1,848

Liability for cash-settled share-based awards assumed from Ironshore Acquisition

2,435

3,044

Accrued income taxes

797

8,525

Accrued severance expense related to Ironshore Acquisition

510

Accrued other operating costs

6,375

4,758

Total accrued liabilities

$

51,468

$

72,124

During the three months ended September 30, 2025, the Company recognized a $3,058 accrual related to the Company’s license agreement with Grünenthal, which was paid in October 2025 and is included as a component of accrued royalties as of September 30, 2025. The accrual relates to the timing of royalty payments due under the license agreement, as confirmed through an arbitration process. The $3,058 accrual was recorded as a component of cost of product revenues in the three months ended September 30, 2025 and is a contingency subject to recovery. Recoveries will be recognized within cost of product revenues when realized.